Cytomodulating peptide for inhibiting lymphocyte activity

摘要

Novel oligopeptides includes associated 1 structural domains of sequence HLA-B α, but provides the cytotoxicity and natural killer cells for inhibiting CTLs including tyrosine tyrosine, tryptophan triad. By the cell and cell for making the present composition with including cytotoxic cell mixture, otherwise these activating cytotoxic cells, cell dissolution target cell can inhibit substantially. The oligopeptides can have different variations by the activity of a variety of other groups or the compound present composition. The composition can be from any convenient mode to host, to inhibit CTL and NK to attack tissue, especially to xenogenesis or homograft.